Crewe Advisors’s Xenetic Biosciences XBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12
| Closed | – | – | 1308 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1164 |
|
|
2022
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 505 |
|
|
2021
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 468 |
|
|
2021
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 471 |
|
|
2021
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 488 |
|
|
2021
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 488 |
|
|
2020
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 655 |
|
|
2020
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 640 |
|
|
2020
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 229 |
|
|
2020
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 249 |
|
|
2019
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 281 |
|
|
2019
Q3 | $0 | Buy |
+12
| New | – | ﹤0.01% | 313 |
|